Search Results 7091-7100 of 34608 for oral

1. Phase 3 Study Of Daraxonrasib (RMC-6236) In Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) - Mayo Clinic

   * Able to take oral medications. Exclusion Criteria: * Prior therapy with direct RAS-targeted therapy (eg. degraders and/or inhibitors). * History of or ...

2. A Study to Evaluate Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients with Dyskeratosis Congenita - Mayo Clinic

   Diagnosis of dyskeratosis congenita based on clinical triad of abnormalities of skin pigmentation, nail dystrophy, oral leukoplakia; OR one of clinical ...

3. Jill Adamski, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

   1st Place - Oral Presentation5th Annual MSTP Scientific Retreat, University of Alabama at Birmingham. 2003. Training Program in Rheumatic Diseases Research ...

4. Head and Neck Cancer Center - Doctors - Mayo Clinic

   outh care, Dental surgery, Oral appliance therapy, Cancer, Oral and throat cancer, Mouth cancer, Head and neck cancer, Facial deformity, Jaw tumors and ...

5. Siddhartha Yadav, M.B.B.S., M.D. - Doctors and Medical Staff - Mayo Clinic

   Third Prize, Oral Presentation, 22nd East Asian Medical Students' ConferenceAsian Medical Students' Association. 2008. Clegg ScholarshipBritish Medical ...

6. Systemic Synuclein Sampling Study (S4) - Clinical Trials

   Has a diagnosis of diabetes mellitus requiring either an oral agent or insulin therapy. A bleeding diathesis, or clinically significant coagulopathy or ...

7. A Study to Evaluate Practical Anemia Bundle for SusTained Blood Recovery - Mayo Clinic

   enrollment, exclusive of oral iron for general nutritional support (e.g. multivitamin with iron) - Severe anemia prior to hospitalization (i.e. hemoglobin ...

8. Clinical Trials - Rivet PVS Therapy in Group 2C

   ≥ 1 HF hospitalization, or healthcare facility with IV diuretics or intensification of oral diuresis for HF within 12 months, or NT-pro BNP value > 400 pg/mL ...

9. Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis - Mayo Clinic

   ... oral absorption (including difficulty swallowing) * New York Heart Association (NYHA) Class III or IV heart failure * Mayo stage three-B (IIIB) with N ...

10. TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

    ... oral cavity primaries regardless of HPV status (per American Joint Committee on Cancer [AJCC] Staging, 8th edition). - Has available archived or fresh core ...